Apellis Pharmaceuticals Inc Stock Ownership - Who owns Apellis Pharmaceuticals?

Insider buying vs selling

Have Apellis Pharmaceuticals Inc insiders been buying or selling?
A. Sinclair DunlopDirector2024-04-121,500$13.19
Pascal DeschateletsChief Scientific Officer2024-04-0869,107$3.76
Pascal DeschateletsChief Scientific Officer2024-04-084,728$54.92
Pascal DeschateletsChief Scientific Officer2024-04-0864,379$54.12
Timothy Eugene SullivanChief Financial Officer2024-04-014,000$58.66
Timothy Eugene SullivanChief Financial Officer2024-04-014,000$10.03
A. Sinclair DunlopDirector2024-03-1918,681$57.18
Mark Jeffrey DelongChief Business Strat Officer2024-03-189,913$56.90
James George ChopasVPChief Accounting Officer2024-03-15184$56.46
Nur NicholsonChief Technical Officer2024-03-137,768$57.31

1 of 15

APLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLS insiders and whales buy or sell their stock.

APLS Shareholders

What type of owners hold Apellis Pharmaceuticals Inc stock?
Wellington Management Group LLP13.64%16,445,290$789.87MInstitution
Morningside Venture Investments Ltd10.62%12,806,342$615.09MInsider
Ecor1 Capital LLC9.27%11,173,068$536.64MInstitution
Avoro Capital Advisors LLC9.21%11,111,111$533.67MInstitution
Vanguard Group Inc7.92%9,555,678$458.96MInstitution
T Rowe Price Investment Management Inc5.23%6,303,584$302.76MInstitution
Blackrock Inc4.46%5,381,253$258.46MInstitution
Potentia Holdings LLC3.17%3,826,601$183.79MInsider
Venbio Global Strategic Fund Ii LP2.97%3,579,305$171.91MInsider
Hillhouse Capital Management Ltd2.93%3,527,152$169.41MInsider

1 of 3

APLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLS74.88%25.12%Net BuyingNet Selling
RVMD89.46%10.54%Net SellingNet Selling
IONS96.31%3.69%Net SellingNet Selling
BPMC81.64%18.36%Net SellingNet Selling
VKTX75.97%9.93%Net SellingNet Selling

Apellis Pharmaceuticals Stock Ownership FAQ

Who owns Apellis Pharmaceuticals?

Apellis Pharmaceuticals (NASDAQ: APLS) is owned by 94.33% institutional shareholders, 31.65% Apellis Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Apellis Pharmaceuticals shareholder, owning 12.81M shares representing 10.62% of the company. Morningside Venture Investments Ltd's Apellis Pharmaceuticals shares are currently valued at $608.43M.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.